Documenti analoghi

• Revisiting the steatosis‐associated fibrosis estimator score in young Asian subjects with steatotic liver disease and consideration for population variability
  di: Jiwon Yang, et al.
  Pubblicazione: (2024)
• Prevalence, proportions of elevated liver enzyme levels, and long‐term cardiometabolic mortality of patients with metabolic dysfunction‐associated steatotic liver disease
  di: Yi‐Ting Chen, et al.
  Pubblicazione: (2024)
• Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis
  di: Kazuma Mori, et al.
  Pubblicazione: (2024)
• Lower hepatocellular carcinoma surveillance in metabolic dysfunction‐associated steatotic liver disease: Impact on treatment eligibility
  di: Connor Henry‐Blake, et al.
  Pubblicazione: (2024)
• Association of metabolic dysfunction‐associated steatotic liver disease with erosive esophagitis development: a longitudinal observational study
  di: Masahiro Sogabe, et al.
  Pubblicazione: (2024)